Status:
COMPLETED
Establishment and Characterization of Meningioma Patient-derived Organoids
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Meningioma
Eligibility:
All Genders
18+ years
Brief Summary
In this study, meningioma organoids will be established from patients' tissues and the characterization of the organoid will be performed.
Detailed Description
Aims and Hypothesis to be tested: The investigators hypothesized that the derived organoid should have a similar morphological and genetic mutation signatures to the patient primary tissue. Study pe...
Eligibility Criteria
Inclusion
- Adult patients (aged \>18 years) with meningioma
- Admission into Prince Wales hospitals neurosurgical services
- Patients with surgical needs of meningioma removal
Exclusion
- 1\. Patients (or next-of-kin as appropriate) refuse to participate into the study
Key Trial Info
Start Date :
May 23 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04478877
Start Date
May 23 2020
End Date
August 31 2023
Last Update
September 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Surgery, The Chinese University of Hong Kong
Hong Kong, Hong Kong